对II组PAK4抑制的6-aminopyridine衍生物的结构导向发现
Eun Lee1, Jisoo Kim1, Hye-Ji Yoon1
1College of Pharmacy, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul 04310, Republic of Korea.
Bioorganic chemistry
|January 13, 2026
概括
研究人员开发了针对癌症治疗的p21激活激酶4 (PAK4) 的新型6-aminopyridine衍生物. 这些化合物接触到一个独特的子口袋,显示癌细胞增殖的强有力的抑制,并为药物发现提供了新的见解.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- p21-激活激酶4 (PAK4) 是一种氨酸/氨酸激酶,参与癌症进展和免疫逃避.
- 在抗癌药物开发中,PAK4 是一个有前途的治疗标.
研究的目的:
- 设计和合成针对PAK4.4的新型6 - 氨基胺衍生物.
- 为了探索PAK4以前未被充分探索的深度疏水性子口袋,用于抑制剂设计.
主要方法:
- 结构导向药物设计被用来创建新型化合物.
- 进行了结构-活性关系 (SAR) 研究,分子对接和动力学模拟.
- 用酶分析和癌细胞增殖分析来评估化合物的疗效.
主要成果:
- 发现了一系列新型的6 - 氨基胺衍生物,针对PAK4中与Phe461相邻的深疏水子口袋.
- 化合物17和29表现出强烈的酶抑制 (IC50值分别为0.71μM和1.88μM),与ATP竞争性抑制相一致.
- 化合物29有效地抑制了HCT-116 (GI50 23.0 μM) 和A549 (GI50 11.3 μM) 癌细胞系中的增殖.
结论:
- 针对PAK4中未经探索的子口袋提供了一个可行的策略,用于开发新的抗癌药物.
- 已识别的6 - 氨基胺衍生物为发现新型PAK4抑制剂提供了宝贵的分子见解.
相关概念视频
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Diazonium Group Substitution: –OH and –H
3.3K
Nitrous acid, a weak acid, is prepared in situ via the reaction of sodium nitrite with a strong acid under cold conditions. This nitrous acid prepared in situ reacts with primary arylamines to form arenediazonium salts. Such reactions are known as diazotization reactions. As shown in Figure 1, the formation of arenediazonium salts begins with the decomposition of nitrous acid in an acidic solution to give nitrosonium ions.
3.3K
Basicity of Heterocyclic Aromatic Amines
6.9K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.9K


